A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence
Recombinant adeno-associated virus (rAAV) is currently the best vector for gene delivery into the skeletal muscle. However, the 5-kb packaging size of this virus is a major obstacle for large gene transfer. This past decade, many different strategies were developed to circumvent this issue (concatem...
Main Authors: | Marina Pryadkina, William Lostal, Nathalie Bourg, Karine Charton, Carinne Roudaut, Matthew L Hirsch, Isabelle Richard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116300213 |
Similar Items
-
Assessment of Therapeutic Potential of a Dual AAV Approach for Duchenne Muscular Dystrophy
by: Sonia Albini, et al.
Published: (2023-07-01) -
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
by: William Lostal, et al.
Published: (2012-01-01) -
Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer.
by: William E Grose, et al.
Published: (2012-01-01) -
Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.
by: Verena Schoewel, et al.
Published: (2012-01-01) -
Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
by: Eduard Gallardo, et al.
Published: (2011-01-01)